Effective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report
Identifieur interne : 000445 ( Pmc/Checkpoint ); précédent : 000444; suivant : 000446Effective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report
Auteurs : Kevin A. Bobeck ; Arthur W. Holtzclaw ; Tara E. Brown ; Paul A. ClarkSource :
- A&a Practice [ 2575-3126 ] ; 2020.
Abstract
The rapid spread of Coronavirus Disease 2019 (COVID-19) has sparked a search for effective therapies. The discovery that the virus binds the angiotensin-converting enzyme 2 (ACE2) receptor has led to investigation of the renin–angiotensin system for possible therapeutic targets. We present a case of an elderly woman with multiple comorbidities who developed severe acute respiratory distress syndrome (ARDS), a cardiomyopathy, and vasodilatory shock secondary to COVID-19 and was treated with exogenous angiotensin II. She rapidly demonstrated significant hemodynamic improvement without noted adverse effects. Thus, we propose further investigation into possible benefits of angiotensin II in shock secondary to COVID-19.
Url:
DOI: 10.1213/XAA.0000000000001221
PubMed: NONE
PubMed Central: 7172437
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:7172437Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report</title><author><name sortKey="Bobeck, Kevin A" sort="Bobeck, Kevin A" uniqKey="Bobeck K" first="Kevin A." last="Bobeck">Kevin A. Bobeck</name><affiliation><nlm:aff id="aff1"></nlm:aff></affiliation></author><author><name sortKey="Holtzclaw, Arthur W" sort="Holtzclaw, Arthur W" uniqKey="Holtzclaw A" first="Arthur W." last="Holtzclaw">Arthur W. Holtzclaw</name><affiliation><nlm:aff id="aff2">Pulmonary, Walter Reed National Military Medical Center, Bethesda, Maryland.</nlm:aff><wicri:noCountry code="subfield">Maryland.</wicri:noCountry></affiliation></author><author><name sortKey="Brown, Tara E" sort="Brown, Tara E" uniqKey="Brown T" first="Tara E." last="Brown">Tara E. Brown</name><affiliation><nlm:aff id="aff2">Pulmonary, Walter Reed National Military Medical Center, Bethesda, Maryland.</nlm:aff><wicri:noCountry code="subfield">Maryland.</wicri:noCountry></affiliation></author><author><name sortKey="Clark, Paul A" sort="Clark, Paul A" uniqKey="Clark P" first="Paul A." last="Clark">Paul A. Clark</name><affiliation><nlm:aff id="aff1"></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmc">7172437</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172437</idno><idno type="RBID">PMC:7172437</idno><idno type="doi">10.1213/XAA.0000000000001221</idno><idno type="pmid">NONE</idno><date when="2020">2020</date><idno type="wicri:Area/Pmc/Corpus">000207</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000207</idno><idno type="wicri:Area/Pmc/Curation">000207</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000207</idno><idno type="wicri:Area/Pmc/Checkpoint">000445</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000445</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Effective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report</title><author><name sortKey="Bobeck, Kevin A" sort="Bobeck, Kevin A" uniqKey="Bobeck K" first="Kevin A." last="Bobeck">Kevin A. Bobeck</name><affiliation><nlm:aff id="aff1"></nlm:aff></affiliation></author><author><name sortKey="Holtzclaw, Arthur W" sort="Holtzclaw, Arthur W" uniqKey="Holtzclaw A" first="Arthur W." last="Holtzclaw">Arthur W. Holtzclaw</name><affiliation><nlm:aff id="aff2">Pulmonary, Walter Reed National Military Medical Center, Bethesda, Maryland.</nlm:aff><wicri:noCountry code="subfield">Maryland.</wicri:noCountry></affiliation></author><author><name sortKey="Brown, Tara E" sort="Brown, Tara E" uniqKey="Brown T" first="Tara E." last="Brown">Tara E. Brown</name><affiliation><nlm:aff id="aff2">Pulmonary, Walter Reed National Military Medical Center, Bethesda, Maryland.</nlm:aff><wicri:noCountry code="subfield">Maryland.</wicri:noCountry></affiliation></author><author><name sortKey="Clark, Paul A" sort="Clark, Paul A" uniqKey="Clark P" first="Paul A." last="Clark">Paul A. Clark</name><affiliation><nlm:aff id="aff1"></nlm:aff></affiliation></author></analytic><series><title level="j">A&a Practice</title><idno type="eISSN">2575-3126</idno><imprint><date when="2020">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>The rapid spread of Coronavirus Disease 2019 (COVID-19) has sparked a search for effective therapies. The discovery that the virus binds the angiotensin-converting enzyme 2 (ACE2) receptor has led to investigation of the renin–angiotensin system for possible therapeutic targets. We present a case of an elderly woman with multiple comorbidities who developed severe acute respiratory distress syndrome (ARDS), a cardiomyopathy, and vasodilatory shock secondary to COVID-19 and was treated with exogenous angiotensin II. She rapidly demonstrated significant hemodynamic improvement without noted adverse effects. Thus, we propose further investigation into possible benefits of angiotensin II in shock secondary to COVID-19.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Letko, M" uniqKey="Letko M">M Letko</name></author><author><name sortKey="Marzi, A" uniqKey="Marzi A">A Marzi</name></author><author><name sortKey="Munster, V" uniqKey="Munster V">V Munster</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tikellis, C" uniqKey="Tikellis C">C Tikellis</name></author><author><name sortKey="Thomas, Mc" uniqKey="Thomas M">MC Thomas</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Xu, H" uniqKey="Xu H">H Xu</name></author><author><name sortKey="Zhong, L" uniqKey="Zhong L">L Zhong</name></author><author><name sortKey="Deng, J" uniqKey="Deng J">J Deng</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Turner, Aj" uniqKey="Turner A">AJ Turner</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chow, Jh" uniqKey="Chow J">JH Chow</name></author><author><name sortKey="Mazzeffi, Ma" uniqKey="Mazzeffi M">MA Mazzeffi</name></author><author><name sortKey="Mccurdy, Mt" uniqKey="Mccurdy M">MT McCurdy</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tran, K" uniqKey="Tran K">K Tran</name></author><author><name sortKey="Cimon, K" uniqKey="Cimon K">K Cimon</name></author><author><name sortKey="Severn, M" uniqKey="Severn M">M Severn</name></author><author><name sortKey="Pessoa Silva, Cl" uniqKey="Pessoa Silva C">CL Pessoa-Silva</name></author><author><name sortKey="Conly, J" uniqKey="Conly J">J Conly</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gautret, P" uniqKey="Gautret P">P Gautret</name></author><author><name sortKey="Lagier, J C" uniqKey="Lagier J">J-C Lagier</name></author><author><name sortKey="Parola, P" uniqKey="Parola P">P Parola</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Onder, G" uniqKey="Onder G">G Onder</name></author><author><name sortKey="Rezza, G" uniqKey="Rezza G">G Rezza</name></author><author><name sortKey="Brusaferro, S" uniqKey="Brusaferro S">S Brusaferro</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Khanna, A" uniqKey="Khanna A">A Khanna</name></author><author><name sortKey="Ostermann, M" uniqKey="Ostermann M">M Ostermann</name></author><author><name sortKey="Bellomo, R" uniqKey="Bellomo R">R Bellomo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tumlin, Ja" uniqKey="Tumlin J">JA Tumlin</name></author><author><name sortKey="Murugan, R" uniqKey="Murugan R">R Murugan</name></author><author><name sortKey="Deane, Am" uniqKey="Deane A">AM Deane</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Liu, Y" uniqKey="Liu Y">Y Liu</name></author><author><name sortKey="Yang, Y" uniqKey="Yang Y">Y Yang</name></author><author><name sortKey="Zhang, C" uniqKey="Zhang C">C Zhang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chawla, Ls" uniqKey="Chawla L">LS Chawla</name></author><author><name sortKey="Chen, S" uniqKey="Chen S">S Chen</name></author><author><name sortKey="Bellomo, R" uniqKey="Bellomo R">R Bellomo</name></author><author><name sortKey="Tidmarsh, Gf" uniqKey="Tidmarsh G">GF Tidmarsh</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lyon, Ar" uniqKey="Lyon A">AR Lyon</name></author><author><name sortKey="Bossone, E" uniqKey="Bossone E">E Bossone</name></author><author><name sortKey="Schneider, B" uniqKey="Schneider B">B Schneider</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Celi, A" uniqKey="Celi A">A Celi</name></author><author><name sortKey="Cianchetti, S" uniqKey="Cianchetti S">S Cianchetti</name></author><author><name sortKey="Dell Mo, G" uniqKey="Dell Mo G">G Dell’Omo</name></author><author><name sortKey="Pedrinelli, R" uniqKey="Pedrinelli R">R Pedrinelli</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hanify, Jm" uniqKey="Hanify J">JM Hanify</name></author><author><name sortKey="Dupree, Lh" uniqKey="Dupree L">LH Dupree</name></author><author><name sortKey="Johnson, Dw" uniqKey="Johnson D">DW Johnson</name></author><author><name sortKey="Ferreira, Ja" uniqKey="Ferreira J">JA Ferreira</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="case-report"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">A A Pract</journal-id><journal-id journal-id-type="iso-abbrev">A A Pract</journal-id><journal-id journal-id-type="publisher-id">ACC</journal-id><journal-title-group><journal-title>A&a Practice</journal-title></journal-title-group><issn pub-type="epub">2575-3126</issn><publisher><publisher-name>Wolters Kluwer Health, Inc</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">7172437</article-id><article-id pub-id-type="art-access-id">00039</article-id><article-id pub-id-type="doi">10.1213/XAA.0000000000001221</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Effective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Bobeck</surname><given-names>Kevin A.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">*</xref></contrib><contrib contrib-type="author"><name><surname>Holtzclaw</surname><given-names>Arthur W.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">†</xref></contrib><contrib contrib-type="author"><name><surname>Brown</surname><given-names>Tara E.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">†</xref></contrib><contrib contrib-type="author"><name><surname>Clark</surname><given-names>Paul A.</given-names></name><degrees>DO</degrees><xref ref-type="aff" rid="aff1">†</xref></contrib><aff id="aff1">From the Departments of<label>*</label>Internal Medicine</aff><aff id="aff2"><label>†</label>Pulmonary, Walter Reed National Military Medical Center, Bethesda, Maryland.</aff></contrib-group><author-notes><corresp id="c1">Address correspondence to Kevin A. Bobeck, MD, Department of Internal Medicine, Walter Reed National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889. Address e-mail to <email xlink:href="kevin.a.bobeck@gmail.com">kevin.a.bobeck@gmail.com</email>.</corresp></author-notes><pub-date pub-type="collection"><month>4</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>16</day><month>4</month><year>2020</year></pub-date><volume>14</volume><issue>6</issue><fpage>e01221</fpage><lpage>e01221</lpage><history><date date-type="accepted"><day>07</day><month>4</month><year>2020</year></date></history><permissions><copyright-statement>Copyright © 2020 International Anesthesia Research Society</copyright-statement><copyright-year>2020</copyright-year><license license-type="NIH OGC"><license-p>This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.</license-p></license></permissions><self-uri xlink:type="simple" xlink:href="acc-14-e01221.pdf"></self-uri><abstract><p>The rapid spread of Coronavirus Disease 2019 (COVID-19) has sparked a search for effective therapies. The discovery that the virus binds the angiotensin-converting enzyme 2 (ACE2) receptor has led to investigation of the renin–angiotensin system for possible therapeutic targets. We present a case of an elderly woman with multiple comorbidities who developed severe acute respiratory distress syndrome (ARDS), a cardiomyopathy, and vasodilatory shock secondary to COVID-19 and was treated with exogenous angiotensin II. She rapidly demonstrated significant hemodynamic improvement without noted adverse effects. Thus, we propose further investigation into possible benefits of angiotensin II in shock secondary to COVID-19.</p></abstract></article-meta></front></pmc><affiliations><list></list><tree><noCountry><name sortKey="Bobeck, Kevin A" sort="Bobeck, Kevin A" uniqKey="Bobeck K" first="Kevin A." last="Bobeck">Kevin A. Bobeck</name><name sortKey="Brown, Tara E" sort="Brown, Tara E" uniqKey="Brown T" first="Tara E." last="Brown">Tara E. Brown</name><name sortKey="Clark, Paul A" sort="Clark, Paul A" uniqKey="Clark P" first="Paul A." last="Clark">Paul A. Clark</name><name sortKey="Holtzclaw, Arthur W" sort="Holtzclaw, Arthur W" uniqKey="Holtzclaw A" first="Arthur W." last="Holtzclaw">Arthur W. Holtzclaw</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000445 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000445 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= Pmc
|étape= Checkpoint
|type= RBID
|clé= PMC:7172437
|texte= Effective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:NONE" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a StressCovidV1
| This area was generated with Dilib version V0.6.33. |  |